Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
New Indication for Trastuzumab

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 24(2)
Publications
Page Number
43
Legacy Keywords
trastuzumab, monoclonal, antibody, metastatic, breast cancer, human epidermal growth factor receptor 2, HER2, Herceptin, chemotherapy, adverse, side effects, cardiomyopathytrastuzumab, monoclonal, antibody, metastatic, breast cancer, human epidermal growth factor receptor 2, HER2, Herceptin, chemotherapy, adverse, side effects, cardiomyopathy
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 24(2)
Issue
Federal Practitioner - 24(2)
Page Number
43
Page Number
43
Publications
Publications
Article Type
Display Headline
New Indication for Trastuzumab
Display Headline
New Indication for Trastuzumab
Legacy Keywords
trastuzumab, monoclonal, antibody, metastatic, breast cancer, human epidermal growth factor receptor 2, HER2, Herceptin, chemotherapy, adverse, side effects, cardiomyopathytrastuzumab, monoclonal, antibody, metastatic, breast cancer, human epidermal growth factor receptor 2, HER2, Herceptin, chemotherapy, adverse, side effects, cardiomyopathy
Legacy Keywords
trastuzumab, monoclonal, antibody, metastatic, breast cancer, human epidermal growth factor receptor 2, HER2, Herceptin, chemotherapy, adverse, side effects, cardiomyopathytrastuzumab, monoclonal, antibody, metastatic, breast cancer, human epidermal growth factor receptor 2, HER2, Herceptin, chemotherapy, adverse, side effects, cardiomyopathy
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media